4-benzoyloxy-tempo
4-benzoyloxy-tempo structure
|
Common Name | 4-benzoyloxy-tempo | ||
|---|---|---|---|---|
| CAS Number | 3225-26-1 | Molecular Weight | 276.351 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H22NO3 | Melting Point | 99-101 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Name | (1-λ1-oxidanyl-2,2,6,6-tetramethylpiperidin-4-yl) benzoate |
|---|---|
| Synonym | More Synonyms |
| Melting Point | 99-101 °C(lit.) |
|---|---|
| Molecular Formula | C16H22NO3 |
| Molecular Weight | 276.351 |
| Exact Mass | 276.159973 |
| PSA | 29.54000 |
| LogP | 3.14840 |
| Stability | Stable. Incompatible with strong oxidizing agents. |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Risk Phrases | 36/37/38 |
| Safety Phrases | S22-S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
~54%
4-benzoyloxy-tempo CAS#:3225-26-1 |
| Literature: Zakrzewski, Jerzy Monatshefte fuer Chemie, 1990 , vol. 121, # 10 p. 803 - 808 |
|
~%
4-benzoyloxy-tempo CAS#:3225-26-1 |
| Literature: Advanced Synthesis and Catalysis, , vol. 352, # 1 p. 113 - 118 |
|
~%
4-benzoyloxy-tempo CAS#:3225-26-1
Detail
|
| Literature: Helvetica Chimica Acta, , vol. 63, # 1 p. 132 - 147 |
|
Mechanistic analysis of PLGA/HPMC-based in-situ forming implants for periodontitis treatment.
Eur. J. Pharm. Biopharm. 94 , 273-83, (2015) In-situ forming implant formulations based on poly(lactic-co-glycolic acid) (PLGA), acetyltributyl citrate (ATBC), minocycline HCl, N-methyl pyrrolidone (NMP) and optionally hydroxypropyl methylcellul... |
|
|
In-situ forming composite implants for periodontitis treatment: How the formulation determines system performance.
Int. J. Pharm. 486 , 38-51, (2015) Periodontitis is the primary cause of tooth loss in adults and a very wide-spread disease. Recently, composite implants, based on a drug release rate controlling polymer and an adhesive polymer, have ... |
|
|
J. Org. Chem. 55 , 462, (1990)
|
| 4-benzoyloxy-2,6-tetramethylpiperidine-N-oxyl |
| 4-Benzoyloxy-TEMPO Free Radical |
| 4-Hydroxy-TEMPO benzoate,free radical |
| 4-benzoyloxy-2,2,6,6-tetramethylpiperidine-1-oxy |
| 4-Hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl benzoate |
| 4-BzO-TEMPO |
| 4-Benzoyloxy-2,2,6,6-tetramethylpiperidine 1-Oxyl Free Radical |
| [4-(Benzoyloxy)-2,2,6,6-tetramethyl-1-piperidinyl]oxidanyl |
| 1-Piperidinyloxy, 4-(benzoyloxy)-2,2,6,6-tetramethyl- |
| 4-PhCO2-TEMPO |
| 4-benzoyloxy-2,2,6,6-tetramethylpiperidine-1-oxyl |
| 4-Hydroxy-2,2,6,6-tetramethylpiperidine 1-Oxyl Benzoate Free Radical |
| [4-(Benzoyloxy)-2,2,6,6-tetramethylpiperidin-1-yl]oxidanyl |
| MFCD00075563 |
| 1-oxyl-2,2,6,6-tetramethlpiperidin-4-yl benzoate |
| 4-Benzoyloxy-TEMPO |
| 4-Hydroxy-TEMPO-benzoate |